Seung-jung Park
Clinical trials sponsored by Seung-jung Park, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart imaging study aims to predict cardiac events Results expected Dec 2026 (estimated)
- 5,000 heart attack patients tracked for years to see what treatments work best Results expected Dec 2026 (estimated)
- New balloon treatment for heart disease under Real-World study Results expected Dec 2026 (estimated)
- Heart stent showdown: FFR vs. angiography for major artery blockage Results expected Jun 2027 (estimated)
-
Hybrid heart fix combines bypass and stents – but study stalls
Disease control Stopped earlyThis study looked at a hybrid approach for treating multiple blocked heart arteries: a minimally invasive bypass for the main artery plus stents for others. Only 6 people took part before the study was stopped early. The goal was to see if this combination is safe and effective i…
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Heart stent study halted: Real-World data sought
Disease control Stopped earlyThis study looked at how well the BIOFREEDOM stent works in everyday medical practice for people with narrowed heart arteries. Researchers planned to track 218 patients to see rates of death, heart attack, or need for repeat procedures. The study was stopped early, so results are…
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Heart stent study halted early: can a pressure wire improve outcomes?
Knowledge-focused Stopped earlyThis study looked at using a special wire that measures blood pressure inside heart arteries (called FFR) to help doctors decide which blockages to treat with stents. It included 438 people with two or more blockages in the same artery. The study was stopped early, so the results…
Sponsor: Seung-Jung Park • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC